Navigation Links
Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
Date:6/18/2010

ROCKVILLE, Md., June 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Phacilitate Vaccine Forum Barcelona 2010 conference on June 21 and June 22, 2010 at The Fira Palace, Barcelona, Spain.  Dr. Singhvi is participating in the roundtable discussion, 'Getting ready for the next influenza pandemic: How are recent experiences informing ongoing preparedness strategies?' and will also be speaking on the Case Study:  'Update on novel vaccine technologies and platforms that have been developed for the influenza market.'  

About Novavax

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based, recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  In 2009, Novavax launched a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India.  Additional information about Novavax is available on the company's website: www.novavax.com.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
2. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
3. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
4. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
5. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
6. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
7. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
8. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
9. Novavax to Present at 8th Annual BIO Investor Forum 2009
10. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
11. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)...   PDI , a leader in infection prevention ... educational session focused on the role of chlorhexidine gluconate ... the 2017 Annual Scientific Meeting of the Association for ... the Phoenix Convention Center in ... will also feature PDI,s Prevantics® Device Swab ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a leading ... a vibrant charitable donation program -- "Color for ... congenital heart defect research by The Children,s Heart ... the general public are encouraged to download a ... the completed artwork to the gallery on the ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the latest ... Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... include new preclinical and clinical data on Bayer,s marketed portfolio ... pipeline projects. "We ... minds in cancer research at ESMO," said Carsten Brunn ...
Breaking Medicine Technology:
(Date:9/20/2017)... ... September 20, 2017 , ... Five consumer packaged goods (CPG) products were selected ... different categories. Nopavera Plus was named to the short list in the ... West 2017 during presentations at SupplySide Central on Sept. 27 and 28 at Mandalay ...
(Date:9/20/2017)... , ... September 20, 2017 , ... “The Trials I ... and tribulations as he emotionally pens his aspirations and goals to better one’s life ... published author, Jimmy Green, while searching in all the wrong places, found a love ...
(Date:9/20/2017)... ... ... “Psalms of Humidity”: is a fascinating depiction of daily struggles and the inspirational solutions ... God. “Psalms of Humidity” is the creation of published author, David Waldrop, an imperfect ... are the very same things that have shaped him into the man that he ...
(Date:9/19/2017)... ... September 19, 2017 , ... With a series of fundraising ... than $15,000 in just a couple of weeks for those affected by Hurricane ... instructor seminars, organizers expect to double those initial funds with the “Submit Harvey” ...
(Date:9/19/2017)... BETHESDA, MD (PRWEB) , ... September 19, 2017 ... ... of Environmental Compliance and Safety for the President’s Malaria Initiative (PMI) Africa ... of USAID’s Innovation to Action Award. , The Innovation to Action Award, ...
Breaking Medicine News(10 mins):